1-6 of 6
Authors: A M Lincoff
Journal Article
Exploratory mediation analysis of the effect of semaglutide on cardiovascular outcomes in people with overweight or obesity in the SELECT randomised trial Free
European Heart Journal, Volume 45, Issue Supplement_1, October 2024, ehae666.2792, https://doi.org/10.1093/eurheartj/ehae666.2792
Published: 28 October 2024
Journal Article
Red cell distribution width as a predictor of cardiovascular events in high-risk patients with statin intolerance: post-hoc analysis of the CLEAR Outcomes trial Free
European Heart Journal, Volume 45, Issue Supplement_1, October 2024, ehae666.2738, https://doi.org/10.1093/eurheartj/ehae666.2738
Published: 28 October 2024
Journal Article
Longitudinal high-sensitivity C-reactive protein and long-term cardiovascular outcomes in optimally-treated patients with high-risk vascular disease Free
European Heart Journal, Volume 42, Issue Supplement_1, October 2021, ehab724.2513, https://doi.org/10.1093/eurheartj/ehab724.2513
Published: 14 October 2021
Journal Article
P4473Baseline insulin levels are associated with need for revascularization among diabetic patients with high risk vascular disease: insights from the ACCELERATE trial Get access
European Heart Journal, Volume 39, Issue suppl_1, August 2018, ehy563.P4473, https://doi.org/10.1093/eurheartj/ehy563.P4473
Published: 28 August 2018
Journal Article
An overview of the results of the EPIC trial Get access
European Heart Journal, Volume 16, Issue suppl_L, November 1995, Pages 43–49, https://doi.org/10.1093/eurheartj/16.suppl_L.43
Published: 01 November 1995
Journal Article
Early clinical experience with integrelin, an inhibitor of the platelet glycoprotein IIb/IIIa integrin receptor Get access
European Heart Journal, Volume 16, Issue suppl_L, November 1995, Pages 50–55, https://doi.org/10.1093/eurheartj/16.suppl_L.50
Published: 01 November 1995
